Augurex Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025

Contributed by: Business Wire

Logo

Tags

Biotechnology

Other Health

Health

Science

Research

More Like This

Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat®, Expanding Access to Cutting-Edge Rheumatoid Arthritis Testing in Great Britain

Augurex Life Sciences Granted FDA Breakthrough Designation for SPINEstat®, its First-in-Class Diagnostic Test for Axial Spondyloarthritis

Augurex Announces UKCA Authorization for SPINEstat™, Expanding Access to a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis to Great Britain

Sobi showcases new data across rare inflammatory conditions at ACR 2025

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

PR Newswire associated0

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress

Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting